New therapies have raised Medicare treatment costs for metastatic prostate cancer
Newswise — December 20, 2022 – Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years – reflecting increased use of new…
Read more New therapies have raised Medicare treatment costs for metastatic prostate cancer